InvestorsHub Logo
Followers 83
Posts 36200
Boards Moderated 0
Alias Born 03/09/2010

Re: SkyLimit2022 post# 547080

Saturday, 12/10/2022 5:02:01 PM

Saturday, December 10, 2022 5:02:01 PM

Post# of 687933
It is a silly argument, as Pazdur himself notes there is a trend toward more acceptance of ECAs, it s not the case yet in oncology, That and other methodological issues with the study will likely make FDA approval difficult at best

THEY HATE ME CAUSE THEY AINT ME

NAILED IT ON EVERY STOCK

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News